Aquestive Therapeutics Inc AQST

Healthcare

Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on treating diseases of the central nervous system (CNS). Its PharmFilm technology is comprised of proprietary polymer compositions that serve as film formers to hold active pharmaceutical ingredients (APIs), and excipients in place. Its product portfolio and pipeline include Anaphylm, AQST-108, and Adrenaverse. Its CNS product candidate include Libervant. The Company’s Licensed commercial products and product candidates and other product includes Suboxone, Exservan, KYNMOBI, Zuplenz, Azstarys, Libervant, and Sympazan. Anaphylm is a non-device based, orally delivered epinephrine product candidate.

NDAQ:AQST - Post by User

Aquestive Therapeutics Inc > This company is a GEM

Bullboard Posts

Next >>

Post by Northernvinceon Aug 20, 2020 10:15pm

172 Views

Post# 31436743

This company is a GEM

If they got the FDA aproval for their first of its kind "sublingual epipen oral film" , this stock's gonna go to 30$... and with their FDA fast track designation they got very good chance to get it before 2021...epinephrine is a multi billions blobal market , epipen is 500-600$ in USA... i wont be surprised if they got a billion MC in early 2021...GLTA

Bullboard Posts

Next >>

The art of taking a flyer: How to play the latest meme stock rally